Overview
- Explains why anti-angiogenic therapy is effective for various ocular diseases
- Highlights the advantages and limitations of anti-angiogenic therapy
- Written by established experts in their respective fields
Part of the book series: Essentials in Ophthalmology (ESSENTIALS)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
Similar content being viewed by others
Keywords
Table of contents (11 chapters)
-
Front Matter
-
Back Matter
Editors and Affiliations
About the editor
Andreas Stahl, MD, FEBO, graduated in Medicine from the University of Freiburg, Germany, in 2005. He spent the years 2008-2010 as a Research Fellow in the Department of Ophthalmology, Harvard Medical School, Boston, thanks to a DFG fellowship grant. Since 2011, Dr. Stahl has been Head of the Angiogenesis Research Group at the University Eye Hospital Freiburg, investigating the underlying mechanisms of angioproliferative retinal diseases. Clinically, Dr. Stahl works as a retinal surgeon attending to patients with a broad variety of retinal disorders ranging from retinopathy of prematurity to ischemic retinopathies and age-related maculopathy. Dr. Stahl has been the recipient of numerous awards, including the Innovative Research Award from the German Ophthalmic Society. He is a reviewer for many journals and author of more than 40 articles in peer-reviewed journals as well as several book chapters.
Bibliographic Information
Book Title: Anti-Angiogenic Therapy in Ophthalmology
Editors: Andreas Stahl
Series Title: Essentials in Ophthalmology
DOI: https://doi.org/10.1007/978-3-319-24097-8
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-24095-4Published: 25 May 2016
Softcover ISBN: 978-3-319-79580-5Published: 26 May 2018
eBook ISBN: 978-3-319-24097-8Published: 13 May 2016
Series ISSN: 1612-3212
Series E-ISSN: 2196-890X
Edition Number: 1
Number of Pages: X, 193
Number of Illustrations: 3 b/w illustrations, 23 illustrations in colour
Topics: Ophthalmology, Angiology